The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MRMD | -34.25% | -38.5% | -9.27% | -75% |
| S&P | +13.96% | +91.24% | +13.85% | +186% |
MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. It focuses on the development, operation, management, and optimization of facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis and cannabis-infused products. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.
The upside these stocks possess may significantly outweigh their risks.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $40.76M | 0.4% |
| Gross Profit | $9.34M | -2.0% |
| Gross Margin | 22.90% | -0.6% |
| Market Cap | $58.45M | -10.7% |
| Market Cap / Employee | $0.07M | 0.0% |
| Employees | 832 | 15.4% |
| Net Income | -$2.94M | -195.6% |
| EBITDA | $4.53M | 3.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $6.60M | -32.6% |
| Accounts Receivable | $8.82M | 19.6% |
| Inventory | 40 | 14.5% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $94.59M | -5.5% |
| Short Term Debt | $6.53M | -21.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -8.55% | -1.5% |
| Return On Invested Capital | 0.96% | 62.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $2.12M | 220.1% |
| Operating Free Cash Flow | $2.68M | 233.3% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.63 | 0.58 | 0.44 | 0.97 | 4.20% |
| Price to Sales | 0.28 | 0.23 | 0.17 | 0.37 | -10.34% |
| Price to Tangible Book Value | 1.29 | 1.32 | 1.35 | 3.00 | 56.32% |
| Price to Free Cash Flow TTM | 35.63 | - | |||
| Enterprise Value to EBITDA | 71.43 | 64.07 | 27.67 | 33.36 | -9.70% |
| Free Cash Flow Yield | 2.8% | - | |||
| Return on Equity | -18.3% | -24.8% | -24.4% | -28.4% | 52.02% |
| Total Debt | $107.47M | $102.24M | $101.75M | $101.12M | -6.75% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
